申请人:BIOGEN IDEC MA INC.
公开号:US20150210647A1
公开(公告)日:2015-07-30
Disclosed are bicyclic aryl compounds of formula (I), that can modulate the activity of the autotaxin (ATX) enzyme. This invention further relates to compounds that are ATX inhibitors, and methods of making and using such compounds in the treatment of demyelination due to injury or disease, as well as for treating proliferative disorders such as cancer.
本发明公开了式(I)的双环芳基化合物,可以调节自体移行素(ATX)酶的活性。本发明还涉及ATX抑制剂化合物以及制备和使用这种化合物治疗因损伤或疾病引起的脱髓鞘和治疗增生性疾病如癌症的方法。